| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | -0.11 | 0.001 |
| mRNA | Compound 23 citrate | CTRPv2 | pan-cancer | AAC | -0.12 | 0.002 |
| mRNA | BRD-K79669418 | CTRPv2 | pan-cancer | AAC | 0.18 | 0.002 |
| mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | KHS101 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.002 |
| mRNA | chlorambucil | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.21 | 0.002 |
| mRNA | PHA-793887 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | PL-DI | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |